SKIPPACK, Pa., Sept. 27, 2013 /PRNewswire/ -- GeoInvesting ("We" or "The GeoTeam") has just released a bullish analysis on Polydex Pharmaceuticals Ltd. (OTC Pink: POLXF), a pharmaceutical company that the research firm qualified as a GeoBargain on July 22, 2013 at $0.81 per share. Please see, "Industry Landscape Opens Doors for Pharmaceutical Company Polydex."
GeoBargains are stocks that meet a number of investment criteria that can translate into superior investment returns. GeoInvesting's approach to identifying potential GeoBargains typically includes:
GeoInvesting's primary focus is to find opportunities in real revenue-generating micro-cap companies with reasonable capital structures.
The GeoTeam's two most recent stocks to be coded as GeoBargains were Gain Capital Holdings and Global Telecom & Tech Inc. Gain Capital Holdings shares are up over 140% since being coded as a GeoBargain on June 6, 2013. We highlighted the company in our article "Double Your Gains with Gain Capital Holdings".
Global Telecom & Tech Inc shares are up over 30% since being coded as a GeoBargain on July 31, 2013. We highlighted the company in our article "Global Telecom: Near-Term Catalysts Should Close Relative Valuation Gap."
We believe POLXF will capitalize on its own set of catalysts, enabling the company to enter a new phase in its growth cycle and resulting in a potential increase in share price from current levels of around $1.10, or 36% higher than our initial mention of POLXF to our premium members.
To be among the first to receive investment ideas like these, please subscribe to our premium service!
About GeoInvesting, LLC
At GEO, our focus is on providing high quality insights on mid and micro cap equities, both in the China and U.S. spaces. Since our inception, we have come to be known by our GeoBargain selections, a group of stocks with a specific set of criteria that has proven to help them perform better than their peers. We're confident that you will find GEO to be an excellent source of stock research and analysis.
Copyright©2012 PR Newswire.
All rights reserved